UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006027
Receipt number R000007133
Scientific Title Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosis
Date of disclosure of the study information 2011/07/25
Last modified on 2011/07/22 22:26:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosis

Acronym

SERM and Eldecalcitol combination therapy for osteoporosis

Scientific Title

Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosis

Scientific Title:Acronym

SERM and Eldecalcitol combination therapy for osteoporosis

Region

Japan


Condition

Condition

Osteoporosis

Classification by specialty

Endocrinology and Metabolism Geriatrics Obstetrics and Gynecology
Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of combination therapy by SERM and Eldecalcitol for patients with osteoporosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of bone mineral density

Key secondary outcomes

(1)Number of fracturs occured
(2)Vertebral deformity
(3)Number of falls
(4)Grip power
(5)Changes of bone metabolic markers
(6)Changes of bone quarity makers
(7)Changes of QOL points


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Raloxifene

Interventions/Control_2

Raloxifene + Alfacalcidol(1.0ug/d)

Interventions/Control_3

Raloxifene + Eldecalcitol(0.75ug/d)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1)Primary osteoposi patients
(2)Patients with informed of consent

Key exclusion criteria

(1)Patients with contraindication for the drugs usend in this study
(2)Patients who do not agree with the participation of this study

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Muneaki Ishijima

Organization

Juntendo University School of Medicine

Division name

Department of Orthopaedics

Zip code


Address

2-1-1, Hongo, Bunkyo-ku, Tokyo

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Muneaki Ishijima

Organization

Juntendo Hospital

Division name

Department of Orthopaedics

Zip code


Address

2-1-1, Hongo, Bunkyo-ku, Tokyo

TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Medicine for Motor Organ, Juntendo University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Medicine for Motor Organ, Juntendo University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2011 Year 07 Month 15 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 07 Month 22 Day

Last modified on

2011 Year 07 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007133


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name